Existing backer Legend Capital contributed to an eight-figure dollar round for the Tsinghua-backed chemistry services provider.
Bellen, a China-based chemistry services provider backed by a Tsinhua University affiliate, has received tens of millions of dollars in a series D round co-led by Huagai Capital and Eastern Bell Capital, DealStreetAsia reported yesterday.
Legend Capital, the venture capital firm spun off by conglomerate Legend Holdings, as well as CICC Capital’s CICC Qichen fund, Apricot Capital and Insight Capital also invested.
Bellen provides chemistry services for pharmaceutical developers, assisting with chemical synthesis and the development of research and manufacturing processes. The cash will support the upgrade of its contract research and development and manufacturing offering.
Apricot Capital, financial services firm China Merchants Bank and Qianhai Fund of Funds co-led a nine-figure renminbi round for the company in late 2018.
Legend Capital co-led Bellen’s $38m series B round in the year before with China International Capital’s Zhongjinqichen fund, investing alongside video game developer Dianjing Shijie,…
